May 7, 2025 03:42 PM EDT

FDA will convene vaccine advisors to discuss Covid strain updates

Max Bayer

Pharma Reporter

FDA advisors will meet later this month to discuss which Covid-19 strain vaccine makers should target ahead of the the fall and winter, when infections …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA will convene vaccine advisors to discuss Covid strain updates

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

What Vinay Prasad means for CBER, vaccines, drug approvals and more

Biotech stocks plunge and industry figures left to wonder after Prasad's FDA appointment

CRISPR Therapeutics' gene editing therapy reduces bad cholesterol and triglycerides by as much as 80%

FDA picks controversial doctor Vinay Prasad as CBER director, in about-face from Marks

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges

FDA will con­vene vac­cine ad­vi­sors to dis­cuss Covid strain up­dates

Pharma Reporter

Sign up to read this article for free.

ImmunityBio, Inc.

Remote

FDA will convene vaccine advisors to discuss Covid strain updates